Ilika plc (LON:IKA), the UK pioneer in solid state battery technology, has announced it has successfully delivered its initial batch of commercial grade Stereax electrode to Cirtec Medical for Stereax M300 production.
In January 2026, Ilika that Cirtec had initiated the commercial electrode supply arrangement with Ilika to support product manufacturing. Ilika has now fulfilled the initial order, its first revenue-generating order from Cirtec.
The electrodes will be used in Stereax M300 batteries for validation and customer sampling across a wide range of active implantable medical device (AIMD) applications, including powering implanted sensors, neurostimulators, orthopaedic implants, orthodontic wearables and ophthalmology devices.
Shawn Martin, Vice President at Cirtec Medical, said: “Our close technical cooperation with Ilika has developed into an effective operational partnership, ensuring our customers will receive the highest quality product for integration into their devices. “
Graeme Purdy, CEO of Ilika, said: “This milestone demonstrates that Ilika’s facility in the UK can deliver commercial-grade electrodes to support Cirtec’s M300 manufacturing activities. We look forward to ramping our supply activities to meet customer demand.”
